More than 25 million Americans have diabetes. For many, multiple daily finger sticks are a painful reality. The development of the LighTouch^® monitor holds the promise of truly pain free and non-invasive daily testing, with accuracy equal to the finger-stick method.

LighTouch technology derives its measurement from blood without removing blood from the body. Without any sensation whatsoever, light of a very specific color is projected into the user’s fingertip, and the different colored light that is subsequently re-projected from the fingertip is carefully analyzed, yielding accurate Blood Glucose results.

Clinical trials of the glucose monitor began in 1999 in partnership with the Joslin Diabetes Center in Syracuse, New York. Since that time, progressively faster, more accurate and more precise measurements have become possible using progressively less expensive and smaller prototypes.

LTM is on track to submit a professional version of the LighTouch non-invasive glucose monitoring device to the FDA. Current projections anticipate the miniaturized home version, or PMD (Personal Medical Device), will follow within six to nine months.